Patents by Inventor Debra BENSEN-KENNEDY

Debra BENSEN-KENNEDY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200115436
    Abstract: The present invention relates to prophylactic dosing regimens with about 90-110 IU/kg long-acting factor IX (human FIX-human albumin) in dosing intervals of about three weeks (e.g., 21 days).
    Type: Application
    Filed: June 29, 2018
    Publication date: April 16, 2020
    Inventors: Yanyan LI, Debra BENSEN-KENNEDY, Iris JACOBS, Christine VOIGT
  • Publication number: 20170042981
    Abstract: The present invention relates to dosing regimens with half-life extended Factor VIIa (FVIIa) for prophylactic and “on-demand” treatment of bleeding, as well as for preventing a bleeding episode during or after surgery in patients with congenital or acquired bleeding disorders. The present invention further relates to the use of half-life extended FVIIa for treating or preventing blood loss in patients without bleeding disorders in situations of hemorrhage, i.e., due to trauma or surgery. Another aspect of the invention is the treatment of acquired haemophilia.
    Type: Application
    Filed: March 30, 2015
    Publication date: February 16, 2017
    Applicant: CSL LIMITED
    Inventors: Debra BENSEN-KENNEDY, Alex VELDMAN, Sabine ZOLLNER, Eva HERZOG
  • Publication number: 20160346366
    Abstract: The present invention relates to prophylactic dosing regimens with long-acting factor IX (FIX) in dosing intervals of 1 week or longer, including (but not limited to) 10 days or longer, such as two weeks, three weeks or even monthly.
    Type: Application
    Filed: December 1, 2014
    Publication date: December 1, 2016
    Inventors: Iris JACOBS, Debra BENSEN-KENNEDY, Christine VOIGT